Followers
0
Following
0
Blog Posts
0
Threads
919
Blogs
Threads
Portfolio
Follower
Following
2019-10-02 09:38 | Report Abuse
And they got no money and no shares only talk hahahahah
2019-10-02 09:32 | Report Abuse
And they got no money and no shares only talk hahahahah
2019-10-01 16:36 | Report Abuse
Maintain BUY and Raising Our 12-month Target Price
We make no changes to our earnings forecasts due to a lack of details on the incremental interest cost, but raise our SOTP-based target price to RM0.45 (from RM0.34) after incorporating a lower WACC of 6.5% (from 7.3%) to reflect lower stock volatility, in view of the improving business outlook. Our revised target price implies a 8x FY20 PER, in line with the preKraken impairment valuation in 2018. Downside risks include weaker-thanexpected OSV fleet utilization, continual late deployment of subsea vessels and termination of existing FPSO contracts.
Source: Affin Hwang Research - 27 Sept 2019
2019-10-01 16:36 | Report Abuse
Maintain BUY and Raising Our 12-month Target Price
We make no changes to our earnings forecasts due to a lack of details on the incremental interest cost, but raise our SOTP-based target price to RM0.45 (from RM0.34) after incorporating a lower WACC of 6.5% (from 7.3%) to reflect lower stock volatility, in view of the improving business outlook. Our revised target price implies a 8x FY20 PER, in line with the preKraken impairment valuation in 2018. Downside risks include weaker-thanexpected OSV fleet utilization, continual late deployment of subsea vessels and termination of existing FPSO contracts.
Source: Affin Hwang Research - 27 Sept 2019
2019-10-01 16:36 | Report Abuse
Maintain BUY and Raising Our 12-month Target Price
We make no changes to our earnings forecasts due to a lack of details on the incremental interest cost, but raise our SOTP-based target price to RM0.45 (from RM0.34) after incorporating a lower WACC of 6.5% (from 7.3%) to reflect lower stock volatility, in view of the improving business outlook. Our revised target price implies a 8x FY20 PER, in line with the preKraken impairment valuation in 2018. Downside risks include weaker-thanexpected OSV fleet utilization, continual late deployment of subsea vessels and termination of existing FPSO contracts.
Source: Affin Hwang Research - 27 Sept 2019
2019-10-01 16:36 | Report Abuse
Maintain BUY and Raising Our 12-month Target Price
We make no changes to our earnings forecasts due to a lack of details on the incremental interest cost, but raise our SOTP-based target price to RM0.45 (from RM0.34) after incorporating a lower WACC of 6.5% (from 7.3%) to reflect lower stock volatility, in view of the improving business outlook. Our revised target price implies a 8x FY20 PER, in line with the preKraken impairment valuation in 2018. Downside risks include weaker-thanexpected OSV fleet utilization, continual late deployment of subsea vessels and termination of existing FPSO contracts.
Source: Affin Hwang Research - 27 Sept 2019
2019-10-01 16:36 | Report Abuse
Maintain BUY and Raising Our 12-month Target Price
We make no changes to our earnings forecasts due to a lack of details on the incremental interest cost, but raise our SOTP-based target price to RM0.45 (from RM0.34) after incorporating a lower WACC of 6.5% (from 7.3%) to reflect lower stock volatility, in view of the improving business outlook. Our revised target price implies a 8x FY20 PER, in line with the preKraken impairment valuation in 2018. Downside risks include weaker-thanexpected OSV fleet utilization, continual late deployment of subsea vessels and termination of existing FPSO contracts.
Source: Affin Hwang Research - 27 Sept 2019
2019-10-01 16:36 | Report Abuse
Maintain BUY and Raising Our 12-month Target Price
We make no changes to our earnings forecasts due to a lack of details on the incremental interest cost, but raise our SOTP-based target price to RM0.45 (from RM0.34) after incorporating a lower WACC of 6.5% (from 7.3%) to reflect lower stock volatility, in view of the improving business outlook. Our revised target price implies a 8x FY20 PER, in line with the preKraken impairment valuation in 2018. Downside risks include weaker-thanexpected OSV fleet utilization, continual late deployment of subsea vessels and termination of existing FPSO contracts.
Source: Affin Hwang Research - 27 Sept 2019
2019-09-30 22:45 | Report Abuse
ckca you comment not only baseless I think your mind have serious Compulsive、Neuropathy psycho/psychopat problem, go seek help to your pig
Mother
2019-09-30 21:02 | Report Abuse
John you comment not only baseless I think your mind have serious Compulsive、Neuropathy psycho/psychopat problem, go seek help to your pig
Mother
2019-09-30 19:27 | Report Abuse
you said ckco ?ckca? YES.....they are .......,hahaha
2019-09-30 16:50 | Report Abuse
hahaha shot also gain money armada armada armada.......ckca still talk?
2019-09-30 08:24 | Report Abuse
Maintain BUY, with a higher TP: RM0.44. We are keeping our BUY rating on the stock with higher SOP-driven TP of RM0.44/share (from RM0.34 previously). This is premised upon (i) the incorporation of the ONGC Kakinada 98/2 FPSO to our SOP (+RM0.05); assuming firm and extension period, 6.1% WACC, capex of USD1bn and 80:20 debt equity funding structure and (ii) updating net debt figures from FY18 to 1H19. Our TP of RM0.44 has an implied FY19 P/E of 10.5x and FY19 P/B of 0.7x. Downside risk to our call would be earnings disappointment arising from Kraken operations and significant highly dilutive cash calls.
2019-09-30 08:02 | Report Abuse
Maintain BUY, with a higher TP: RM0.44. We are keeping our BUY rating on the stock with higher SOP-driven TP of RM0.44/share (from RM0.34 previously). This is premised upon (i) the incorporation of the ONGC Kakinada 98/2 FPSO to our SOP (+RM0.05); assuming firm and extension period, 6.1% WACC, capex of USD1bn and 80:20 debt equity funding structure and (ii) updating net debt figures from FY18 to 1H19. Our TP of RM0.44 has an implied FY19 P/E of 10.5x and FY19 P/B of 0.7x. Downside risk to our call would be earnings disappointment arising from Kraken operations and significant highly dilutive cash calls.
2019-09-30 07:57 | Report Abuse
Ckca thank you to share bankrupt experience.coming................
2019-09-30 07:37 | Report Abuse
Hahaha John l have 10b bought in at 0.15
2019-09-30 07:37 | Report Abuse
hahaha all loser and lost money only way is to talk here sad
2019-09-30 06:38 | Report Abuse
Hahaha in share market valid point always not relevant go to fix deposit rest in your valid point
Stock: [ARMADA]: BUMI ARMADA BERHAD
2019-10-02 09:53 |
Post removed.Why?